Nph Insulin
44 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
44
Total Reports
4
Deaths Reported
910.0%
Death Rate
Active Ingredients
Nph Insulin
Administration Routes
SubcutaneousUnknownParenteral
Species Affected
Dog 43
Cat 1
Most Affected Breeds
Terrier - Jack Russell 4
Pinscher - Miniature 4
Shih Tzu 3
Schnauzer - Miniature 3
Chihuahua 3
Maltese 3
Terrier - Boston 3
Dachshund - Standard Smooth-haired 2
Schnauzer (unspecified) 2
Shepherd (unspecified) 2
Most Reported Reactions
Hyperglycaemia 19
Weight loss 14
Hyperkalaemia 13
Other abnormal test result NOS 8
Hyponatremia 8
Lethargy (see also Central nervous system depression in 'Neurological') 8
Vomiting 8
Low sodium-potassium ratio (Na:K ratio) 7
Hypoglycaemia 7
Elevated alanine aminotransferase (ALT) 7
Elevated serum alkaline phosphatase (SAP) 7
Elevated blood urea nitrogen (BUN) 5
Outcome Breakdown
Outcome Unknown
25 (56.8%)
Ongoing
11 (25.0%)
Recovered/Normal
4 (9.1%)
Euthanized
2 (4.5%)
Died
2 (4.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.